Tweenvest Stocks

Kali, Inc. (OTCPK: KALY)

Health Care · Pharmaceuticals · US

$0.00

-99.00% today · 0.0% 1Y

Kali, Inc. (OTCPK: KALY) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $1.54K and employs 171 people.

Over the last twelve months the share price has gained 0.0%, trading between 0.00 and 0.00.

Tweenvest scores Kali, Inc. across four factors: quality 73/100, value 51/100, growth 90/100. Its strongest factor is growth.

KALY price history

Not enough price history to draw a chart yet.

Key figures

Market cap
$1.54K
Revenue (TTM)
$105.99M
P/E
0.00
EPS
7.96
Dividend yield
Beta (5Y)
-90.90
52-week high
$0.00
52-week low
$0.00
Avg volume (3M)
Shares outstanding
1.54B
Employees
171
Next earnings

About Kali, Inc.

Kali, Inc., which conducts business as Kali-Extracts, Inc., focuses its efforts on the research and development of cannabis-based treatments. The company aims to address a variety of medical conditions, including various illnesses, diseases, and the persistent pain that can accompany diverse diagnoses. Its offerings encompass a range of products, including pharmaceutical preparations, cannabis extracts, and general health and wellness items. The entity was formerly identified as VLOV Inc. until it adopted the name Kali, Inc. in February 2016. Kali, Inc. is headquartered in Dallas, Texas.

ISIN
US4833801016
Listed since
Apr 2, 2008
Exchange
Pink Sheets LLC
Currency
USD
CompanyMarket capPriceDay
Eli Lilly and CompanyNYSE: LLY$1.12T$1,255.40+0.88%
Johnson & JohnsonNYSE: JNJ$651.25B$270.24+1.07%
Merck & Co., Inc.NYSE: MRK$376.37B$152.55+2.39%
Roche Holding AGSWX: ROP$373.91BCHF375.60+1.02%
Novartis AGSWX: NOVN$302.17BCHF127.42+0.85%
AstraZeneca PLCLSE: AZN$258.76B£122.40+1.26%
Novo Nordisk A/SCPSE: NOVO B$207.84BDkr300.85+1.59%
Pfizer Inc.NYSE: PFE$159.99B$28.07+1.01%

Browse every Pharmaceuticals company →

Figures last refreshed Aug 18, 2026.